ER Self-Test could catch cervical cancer earlier

NCT ID NCT07345897

Recruiting now Diagnosis Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering a self-sampling kit for HPV in the emergency department can increase the number of people who get screened for cervical cancer. About 200 eligible individuals (ages 30-65 with a cervix) will be offered the kit while in the ED. The goal is to see if more people follow through with screening compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: self-sampling kit for HPV testing
What this could lead to: If successful, this approach could make cervical cancer screening more accessible and convenient, potentially catching more cases early.
What could go wrong: This is a small, early-stage study focused on feasibility, not on detecting cancer itself. The self-sampling method may not be as accurate as a clinician-collected sample, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER (EARLY DETECTION) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER (EARLY DETECTION) CERVICAL CANCER SCREENING HPV HPV ASSOCIATED CANCERS HPV CANCERS

Contacts and locations

Locations

University of Rochester Strong Memorial Hospital
RECRUITING

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.